GitLab

In the past years, China has actually built a strong foundation to support its AI economy and made substantial contributions to AI internationally. Stanford University's AI Index, wakewiki.de which evaluates AI improvements worldwide across different metrics in research, advancement, and economy, ranks China amongst the leading three countries for global AI vibrancy.1"Global AI Vibrancy Tool: Who's leading the global AI race?" Artificial Intelligence Index, Stanford Institute for Human-Centered Artificial Intelligence (HAI), Stanford University, 2021 ranking. On research, for example, China produced about one-third of both AI journal papers and AI citations worldwide in 2021. In financial investment, China accounted for almost one-fifth of worldwide personal investment funding in 2021, drawing in $17 billion for AI start-ups.2 Daniel Zhang et al., Artificial Intelligence Index report 2022, Stanford Institute for Human-Centered Artificial Intelligence (HAI), Stanford University, March 2022, Figure 4.2.6, "Private financial investment in AI by geographical location, 2013-21."

Five types of AI companies in China

In China, we discover that AI business usually fall into among five main categories:

Hyperscalers establish end-to-end AI innovation ability and work together within the environment to serve both business-to-business and business-to-consumer business. Traditional market business serve consumers straight by developing and adopting AI in internal improvement, new-product launch, and consumer services. Vertical-specific AI companies establish software and services for specific domain use cases. AI core tech companies offer access to computer system vision, natural-language processing, voice recognition, and artificial intelligence capabilities to establish AI systems. Hardware business offer the hardware infrastructure to support AI demand in computing power and storage. Today, AI adoption is high in China in financing, retail, and high tech, which together represent more than one-third of the country's AI market (see sidebar "5 types of AI business in China").3 iResearch, iResearch serial market research on China's AI industry III, December 2020. In tech, for example, leaders Alibaba and ByteDance, both family names in China, have actually ended up being known for their extremely tailored AI-driven customer apps. In truth, many of the AI applications that have been widely embraced in China to date have remained in consumer-facing markets, moved by the world's biggest internet customer base and the ability to engage with consumers in brand-new methods to increase customer loyalty, earnings, and market appraisals.

So what's next for AI in China?

About the research study

This research is based upon field interviews with more than 50 experts within McKinsey and throughout markets, along with substantial analysis of McKinsey market evaluations in Europe, the United States, Asia, and China specifically in between October and November 2021. In performing our analysis, we looked outside of business sectors, such as finance and retail, where there are already mature AI use cases and clear adoption. In emerging sectors with the greatest value-creation capacity, we concentrated on the domains where AI applications are presently in market-entry phases and could have an out of proportion impact by 2030. Applications in these sectors that either remain in the early-exploration stage or have mature industry adoption, such as manufacturing-operations optimization, were not the focus for the purpose of the research study.

In the coming decade, our research study indicates that there is significant chance for AI development in brand-new sectors in China, including some where innovation and R&D costs have generally lagged international equivalents: automobile, transportation, and logistics; manufacturing; business software application; and health care and life sciences. (See sidebar "About the research.") In these sectors, we see clusters of usage cases where AI can create upwards of $600 billion in financial value yearly. (To offer a sense of scale, the 2021 gdp in Shanghai, China's most populated city of nearly 28 million, was roughly $680 billion.) Sometimes, this value will originate from profits created by AI-enabled offerings, while in other cases, it will be generated by expense savings through higher performance and efficiency. These clusters are most likely to end up being battlegrounds for business in each sector that will assist define the market leaders.

Unlocking the complete potential of these AI chances normally needs significant investments-in some cases, much more than leaders may expect-on multiple fronts, including the information and technologies that will underpin AI systems, the ideal talent and organizational frame of minds to construct these systems, and brand-new business designs and collaborations to create information ecosystems, industry requirements, and regulations. In our work and worldwide research, we discover a lot of these enablers are becoming standard practice amongst companies getting the many value from AI.

To help leaders and financiers marshal their resources to speed up, interrupt, and lead in AI, we dive into the research study, first sharing where the biggest opportunities lie in each sector and then detailing the core enablers to be tackled first.

Following the cash to the most appealing sectors

We looked at the AI market in China to determine where AI might deliver the most value in the future. We studied market forecasts at length and dug deep into country and segment-level reports worldwide to see where AI was delivering the greatest worth across the worldwide landscape. We then spoke in depth with experts throughout sectors in China to understand where the best chances might emerge next. Our research study led us to numerous sectors: automotive, transportation, and logistics, which are collectively anticipated to contribute the majority-around 64 percent-of the $600 billion opportunity; manufacturing, which will drive another 19 percent; enterprise software application, contributing 13 percent; and health care and life sciences, at 4 percent of the opportunity.

Within each sector, our analysis shows the value-creation chance concentrated within just 2 to 3 domains. These are generally in locations where private-equity and venture-capital-firm investments have actually been high in the previous five years and successful evidence of principles have been provided.

Automotive, transportation, and logistics

China's auto market stands as the biggest in the world, with the number of cars in usage surpassing that of the United States. The sheer size-which we approximate to grow to more than 300 million traveler cars on the road in China by 2030-provides a fertile landscape of AI chances. Certainly, our research discovers that AI could have the greatest prospective effect on this sector, providing more than $380 billion in economic value. This worth development will likely be generated mainly in three areas: self-governing lorries, customization for auto owners, and fleet property management.

Autonomous, or self-driving, lorries. Autonomous vehicles make up the biggest part of worth creation in this sector ($335 billion). Some of this new worth is expected to come from a reduction in monetary losses, such as medical, first-responder, and automobile expenses. Roadway mishaps stand to decrease an approximated 3 to 5 percent yearly as self-governing cars actively browse their surroundings and make real-time driving choices without undergoing the numerous interruptions, such as text messaging, that lure humans. Value would likewise originate from cost savings realized by chauffeurs as cities and enterprises change guest vans and buses with shared autonomous lorries.4 Estimate based upon McKinsey analysis. Key assumptions: 3 percent of light automobiles and 5 percent of heavy vehicles on the road in China to be replaced by shared autonomous cars; mishaps to be reduced by 3 to 5 percent with adoption of autonomous cars.

Already, considerable progress has been made by both standard automotive OEMs and AI gamers to advance autonomous-driving abilities to level 4 (where the driver does not require to focus however can take control of controls) and level 5 (completely autonomous capabilities in which inclusion of a steering wheel is optional). For circumstances, WeRide, which attained level 4 autonomous-driving abilities,5 Based on WeRide's own assessment/claim on its website. completed a pilot of its Robotaxi in Guangzhou, with nearly 150,000 trips in one year without any accidents with active liability.6 The pilot was performed between November 2019 and November 2020.

Personalized experiences for cars and truck owners. By utilizing AI to evaluate sensor and GPS data-including vehicle-parts conditions, fuel usage, route choice, and steering habits-car producers and AI players can significantly tailor recommendations for software and hardware updates and customize vehicle owners' driving experience. Automaker NIO's sophisticated driver-assistance system and battery-management system, for example, can track the health of electric-car batteries in real time, identify use patterns, and enhance charging cadence to improve battery life span while drivers go about their day. Our research discovers this could provide $30 billion in financial value by decreasing maintenance expenses and unanticipated vehicle failures, along with producing incremental profits for business that recognize ways to monetize software application updates and new abilities.7 Estimate based upon McKinsey analysis. Key assumptions: AI will generate 5 to 10 percent cost savings in client maintenance cost (hardware updates); cars and truck producers and AI gamers will monetize software updates for 15 percent of fleet.

Fleet asset management. AI might likewise show critical in helping fleet supervisors better navigate China's tremendous network of railway, highway, inland waterway, and civil air travel routes, which are a few of the longest on the planet. Our research finds that $15 billion in value development might emerge as OEMs and AI gamers specializing in logistics establish operations research optimizers that can examine IoT data and identify more fuel-efficient paths and lower-cost maintenance picks up fleet operators.8 Estimate based upon McKinsey analysis. Key presumptions: 5 to 15 percent expense reduction in automobile fleet fuel usage and maintenance; around 2 percent expense reduction for aircrafts, vessels, and trains. One vehicle OEM in China now provides fleet owners and operators an AI-driven management system for keeping track of fleet areas, tracking fleet conditions, and examining trips and routes. It is approximated to save up to 15 percent in fuel and maintenance expenses.

Manufacturing

In manufacturing, China is progressing its track record from a low-cost production center for toys and clothing to a leader in precision manufacturing for processors, chips, engines, and other high-end elements. Our findings reveal AI can assist facilitate this shift from manufacturing execution to making development and create $115 billion in economic worth.

Most of this value production ($100 billion) will likely come from innovations in process design through using numerous AI applications, such as collective robotics that produce the next-generation assembly line, and digital twins that reproduce real-world properties for use in simulation and optimization engines.9 Estimate based on McKinsey analysis. Key presumptions: 40 to half expense reduction in producing item R&D based upon AI adoption rate in 2030 and improvement for making design by sub-industry (consisting of chemicals, steel, electronic devices, automobile, and advanced industries). With digital twins, manufacturers, machinery and robotics providers, and system automation companies can imitate, test, and confirm manufacturing-process results, such as item yield or production-line efficiency, before commencing large-scale production so they can recognize expensive process inadequacies early. One local electronic devices manufacturer uses wearable sensors to catch and digitize hand and body motions of workers to design human performance on its production line. It then optimizes devices criteria and setups-for example, by altering the angle of each workstation based on the worker's height-to lower the likelihood of employee injuries while improving worker convenience and performance.

The remainder of value production in this sector ($15 billion) is expected to come from AI-driven enhancements in item advancement.10 Estimate based on McKinsey analysis. Key presumptions: 10 percent expense reduction in manufacturing product R&D based on AI adoption rate in 2030 and enhancement for item R&D by sub-industry (including electronics, equipment, automotive, and advanced markets). Companies could use digital twins to quickly test and verify brand-new product designs to lower R&D costs, enhance product quality, and drive brand-new item innovation. On the global stage, Google has offered a peek of what's possible: it has used AI to rapidly examine how different part layouts will change a chip's power intake, performance metrics, and size. This technique can yield an optimum chip design in a portion of the time style engineers would take alone.

Would you like to find out more about QuantumBlack, AI by McKinsey?

Enterprise software application

As in other nations, companies based in China are undergoing digital and AI transformations, resulting in the development of new local enterprise-software markets to support the needed technological foundations.

Solutions delivered by these business are estimated to provide another $80 billion in economic worth. Offerings for cloud and AI tooling are anticipated to offer more than half of this worth creation ($45 billion).11 Estimate based on McKinsey analysis. Key presumptions: 12 percent CAGR for cloud database in China; 20 to 30 percent CAGR for AI tooling. In one case, a local cloud company serves more than 100 regional banks and insurance companies in China with an incorporated information platform that enables them to operate across both cloud and on-premises environments and decreases the expense of database development and storage. In another case, an AI tool provider in China has developed a shared AI algorithm platform that can assist its information scientists automatically train, predict, and upgrade the model for a given forecast issue. Using the shared platform has actually lowered design production time from three months to about two weeks.

AI-driven software-as-a-service (SaaS) applications are anticipated to contribute the remaining $35 billion in financial value in this category.12 Estimate based upon McKinsey analysis. Key presumptions: 17 percent CAGR for software application market; 100 percent SaaS penetration rate in China by 2030; 90 percent of the usage cases empowered by AI in business SaaS applications. Local SaaS application developers can use multiple AI strategies (for instance, computer vision, natural-language processing, artificial intelligence) to assist companies make predictions and decisions throughout enterprise functions in finance and tax, personnels, supply chain, and cybersecurity. A leading monetary institution in China has released a local AI-driven SaaS service that uses AI bots to use tailored training suggestions to employees based on their career course.

Healthcare and life sciences

In current years, China has stepped up its investment in innovation in healthcare and life sciences with AI. China's "14th Five-Year Plan" targets 7 percent annual growth by 2025 for R&D expenditure, of which at least 8 percent is dedicated to standard research.13"'14th Five-Year Plan' Digital Economy Development Plan," State Council of the People's Republic of China, January 12, 2022.

One area of focus is speeding up drug discovery and increasing the chances of success, which is a substantial international problem. In 2021, worldwide pharma R&D spend reached $212 billion, compared with $137 billion in 2012, with a roughly 5 percent compound annual development rate (CAGR). Drug discovery takes 5.5 years typically, which not only hold-ups patients' access to ingenious therapeutics but also shortens the patent protection period that rewards development. Despite improved success rates for new-drug development, just the top 20 percent of pharmaceutical companies worldwide realized a breakeven on their R&D financial investments after 7 years.

Another leading concern is enhancing client care, and Chinese AI start-ups today are working to build the country's track record for providing more accurate and reputable healthcare in regards to diagnostic results and scientific decisions.

Our research study suggests that AI in R&D might add more than $25 billion in economic worth in three particular areas: much faster drug discovery, clinical-trial optimization, and clinical-decision assistance.

Rapid drug discovery. Novel drugs (patented prescription drugs) currently represent less than 30 percent of the overall market size in China (compared to more than 70 percent globally), showing a considerable chance from presenting novel drugs empowered by AI in discovery. We estimate that utilizing AI to speed up target identification and unique molecules style might contribute as much as $10 billion in value.14 Estimate based on McKinsey analysis. Key presumptions: 35 percent of AI enablement on novel drug discovery; 10 percent income from unique drug development through AI empowerment. Already more than 20 AI start-ups in China funded by private-equity companies or local hyperscalers are collaborating with traditional pharmaceutical business or individually working to develop unique rehabs. Insilico Medicine, by utilizing an end-to-end generative AI engine for target identification, particle design, and lead optimization, found a preclinical prospect for pulmonary fibrosis in less than 18 months at an expense of under $3 million. This represented a considerable decrease from the average timeline of six years and a typical cost of more than $18 million from target discovery to preclinical prospect. This antifibrotic drug candidate has actually now effectively finished a Stage 0 medical research study and went into a Phase I medical trial.

Clinical-trial optimization. Our research suggests that another $10 billion in financial worth could result from enhancing clinical-study designs (process, procedures, websites), optimizing trial shipment and execution (hybrid trial-delivery design), and generating real-world evidence.15 Estimate based on McKinsey analysis. Key presumptions: 30 percent AI usage in medical trials; 30 percent time cost savings from real-world-evidence accelerated approval. These AI use cases can lower the time and cost of clinical-trial development, offer a much better experience for clients and healthcare specialists, and enable higher quality and compliance. For circumstances, a worldwide top 20 pharmaceutical company leveraged AI in combination with process enhancements to minimize the clinical-trial enrollment timeline by 13 percent and save 10 to 15 percent in external expenses. The international pharmaceutical company focused on three locations for its tech-enabled clinical-trial advancement. To speed up trial design and functional planning, it utilized the power of both internal and external information for enhancing procedure design and website choice. For streamlining website and patient engagement, it developed an environment with API requirements to take advantage of internal and external developments. To establish a clinical-trial development cockpit, it aggregated and pictured operational trial information to allow end-to-end clinical-trial operations with complete openness so it could forecast possible threats and trial delays and proactively do something about it.

Clinical-decision assistance. Our findings suggest that making use of artificial intelligence algorithms on medical images and information (including assessment results and sign reports) to predict diagnostic results and support clinical choices could produce around $5 billion in economic worth.16 Estimate based upon McKinsey analysis. Key assumptions: 10 percent greater early-stage cancer diagnosis rate through more precise AI diagnosis; 10 percent boost in effectiveness made it possible for by AI. A leading AI start-up in medical imaging now uses computer system vision and artificial intelligence algorithms on optical coherence tomography arises from retinal images. It immediately browses and determines the indications of lots of chronic health problems and conditions, such as diabetes, high blood pressure, and arteriosclerosis, expediting the medical diagnosis procedure and increasing early detection of disease.

How to unlock these chances

During our research study, we found that recognizing the value from AI would require every sector to drive considerable investment and development across six crucial making it possible for locations (exhibition). The first 4 areas are data, skill, technology, and significant work to shift mindsets as part of adoption and scaling efforts. The remaining 2, ecosystem orchestration and browsing policies, can be thought about collectively as market collaboration and must be attended to as part of technique efforts.

Some specific obstacles in these areas are distinct to each sector. For example, in automotive, transportation, and logistics, equaling the current advances in 5G and connected-vehicle technologies (frequently described as V2X) is vital to unlocking the worth because sector. Those in healthcare will desire to remain present on advances in AI explainability; for providers and patients to rely on the AI, they should be able to understand why an algorithm made the decision or recommendation it did.

Broadly speaking, 4 of these areas-data, talent, innovation, and market collaboration-stood out as common difficulties that our company believe will have an outsized effect on the financial worth attained. Without them, taking on the others will be much harder.

Data

For AI systems to work effectively, they require access to premium information, indicating the data should be available, functional, dependable, appropriate, and secure. This can be challenging without the ideal structures for keeping, processing, and handling the vast volumes of data being produced today. In the automotive sector, for instance, the ability to procedure and support as much as two terabytes of information per vehicle and road data daily is required for making it possible for autonomous lorries to comprehend what's ahead and delivering tailored experiences to human chauffeurs. In healthcare, AI designs require to take in large amounts of omics17"Omics" consists of genomics, epigenomics, transcriptomics, proteomics, metabolomics, interactomics, pharmacogenomics, and diseasomics. information to comprehend diseases, identify brand-new targets, and develop new molecules.

Companies seeing the highest returns from AI-more than 20 percent of earnings before interest and taxes (EBIT) contributed by AI-offer some insights into what it takes to attain this. McKinsey's 2021 Global AI Survey shows that these high entertainers are much more likely to purchase core information practices, such as quickly integrating internal structured information for use in AI systems (51 percent of high entertainers versus 32 percent of other business), developing an information dictionary that is available across their business (53 percent versus 29 percent), and developing distinct procedures for data governance (45 percent versus 37 percent).

Participation in data sharing and information environments is likewise vital, as these partnerships can result in insights that would not be possible otherwise. For instance, medical huge data and AI business are now partnering with a vast array of healthcare facilities and research study institutes, integrating their electronic medical records (EMR) with publicly available medical-research data and clinical-trial information from pharmaceutical business or agreement research study organizations. The objective is to help with drug discovery, clinical trials, and choice making at the point of care so companies can much better determine the best treatment procedures and plan for each client, therefore increasing treatment effectiveness and lowering chances of unfavorable adverse effects. One such business, Yidu Cloud, has actually offered huge information platforms and services to more than 500 medical facilities in China and has, upon permission, evaluated more than 1.3 billion healthcare records considering that 2017 for usage in real-world illness designs to support a variety of usage cases including medical research, medical facility management, and policy making.

The state of AI in 2021

Talent

In our experience, we discover it nearly impossible for services to provide impact with AI without service domain knowledge. Knowing what concerns to ask in each domain can determine the success or failure of an offered AI effort. As a result, organizations in all 4 sectors (vehicle, transport, and logistics; manufacturing; enterprise software application; and healthcare and life sciences) can gain from methodically upskilling existing AI specialists and knowledge workers to become AI translators-individuals who understand what organization concerns to ask and can equate service problems into AI options. We like to think about their skills as resembling the Greek letter pi (π). This group has not only a broad mastery of basic management abilities (the horizontal bar) but also spikes of deep functional knowledge in AI and domain competence (the vertical bars).

To construct this talent profile, some companies upskill technical talent with the requisite abilities. One AI start-up in drug discovery, for instance, has produced a program to train recently worked with data scientists and AI engineers in pharmaceutical domain understanding such as molecule structure and qualities. Company executives credit this deep domain understanding among its AI specialists with enabling the discovery of nearly 30 particles for clinical trials. Other companies seek to arm existing domain skill with the AI abilities they need. An electronics maker has actually developed a digital and AI academy to provide on-the-job training to more than 400 staff members across different functional areas so that they can lead numerous digital and AI tasks throughout the business.

Technology maturity

McKinsey has actually found through previous research that having the best innovation structure is a crucial chauffeur for AI success. For business leaders in China, our findings highlight 4 priorities in this location:

Increasing digital adoption. There is room throughout markets to increase digital adoption. In hospitals and other care suppliers, numerous workflows connected to clients, personnel, and equipment have yet to be digitized. Further digital adoption is required to offer health care organizations with the required information for forecasting a patient's eligibility for a scientific trial or supplying a physician with intelligent clinical-decision-support tools.

The very same is true in production, where digitization of factories is low. Implementing IoT sensors across making equipment and assembly line can allow business to collect the information necessary for powering digital twins.

Implementing data science tooling and platforms. The expense of can be high, and companies can benefit significantly from using innovation platforms and tooling that improve model implementation and maintenance, simply as they gain from investments in innovations to improve the efficiency of a factory production line. Some vital capabilities we advise business think about consist of reusable information structures, scalable calculation power, and automated MLOps capabilities. All of these add to making sure AI teams can work efficiently and proficiently.

Advancing cloud facilities. Our research study discovers that while the percent of IT workloads on cloud in China is almost on par with global survey numbers, the share on private cloud is much bigger due to security and data compliance concerns. As SaaS vendors and other enterprise-software providers enter this market, we advise that they continue to advance their infrastructures to deal with these concerns and provide enterprises with a clear worth proposition. This will need more advances in virtualization, data-storage capacity, performance, elasticity and resilience, and technological dexterity to tailor business capabilities, which enterprises have actually pertained to get out of their vendors.

Investments in AI research and advanced AI methods. A lot of the use cases explained here will require fundamental advances in the underlying technologies and techniques. For example, in production, additional research is needed to improve the efficiency of video camera sensing units and computer system vision algorithms to spot and recognize things in dimly lit environments, which can be common on factory floorings. In life sciences, further innovation in wearable gadgets and AI algorithms is essential to enable the collection, processing, and combination of real-world data in drug discovery, clinical trials, and clinical-decision-support processes. In vehicle, advances for enhancing self-driving design accuracy and minimizing modeling intricacy are required to improve how self-governing automobiles view things and carry out in complicated scenarios.

For carrying out such research, scholastic cooperations in between enterprises and universities can advance what's possible.

Market cooperation

AI can provide challenges that transcend the abilities of any one company, which frequently gives rise to policies and partnerships that can even more AI development. In numerous markets worldwide, we've seen new guidelines, such as Global Data Protection Regulation (GDPR) in Europe and the California Consumer Privacy Act in the United States, begin to resolve emerging concerns such as data privacy, which is considered a top AI relevant threat in our 2021 Global AI Survey. And proposed European Union policies created to attend to the development and use of AI more broadly will have implications internationally.

Our research points to 3 locations where additional efforts could assist China open the complete economic value of AI:

Data personal privacy and sharing. For people to share their data, whether it's healthcare or driving information, they require to have a simple way to permit to utilize their data and have trust that it will be used properly by authorized entities and safely shared and saved. Guidelines connected to personal privacy and sharing can develop more self-confidence and therefore make it possible for higher AI adoption. A 2019 law enacted in China to enhance citizen health, for example, promotes making use of huge information and AI by developing technical requirements on the collection, storage, analysis, and application of medical and health information.18 Law of the People's Republic of China on Basic Medical and Health Care and the Promotion of Health, Article 49, 2019.

Meanwhile, there has been considerable momentum in industry and academia to develop approaches and structures to assist reduce personal privacy concerns. For example, the variety of documents mentioning "privacy" accepted by the Neural Details Processing Systems, a leading artificial intelligence conference, has increased sixfold in the past five years.19 Artificial Intelligence Index report 2022, March 2022, Figure 3.3.6.

Market alignment. In some cases, brand-new company models enabled by AI will raise essential questions around the usage and delivery of AI among the different stakeholders. In health care, for instance, as business develop brand-new AI systems for clinical-decision support, debate will likely emerge among federal government and doctor and payers as to when AI is effective in enhancing medical diagnosis and treatment recommendations and how providers will be repaid when utilizing such systems. In transportation and logistics, problems around how federal government and insurance companies determine fault have actually currently developed in China following mishaps including both autonomous lorries and cars run by human beings. Settlements in these mishaps have actually developed precedents to direct future choices, however further codification can help make sure consistency and clarity.

Standard procedures and procedures. Standards allow the sharing of data within and throughout communities. In the health care and life sciences sectors, academic medical research study, clinical-trial information, and patient medical information need to be well structured and documented in an uniform manner to accelerate drug discovery and scientific trials. A push by the National Health Commission in China to build a data foundation for EMRs and illness databases in 2018 has actually led to some motion here with the development of a standardized disease database and EMRs for usage in AI. However, standards and protocols around how the information are structured, processed, and connected can be helpful for more use of the raw-data records.

Likewise, standards can also remove process delays that can derail development and scare off investors and talent. An example includes the acceleration of drug discovery utilizing real-world evidence in Hainan's medical tourism zone; equating that success into transparent approval procedures can assist guarantee constant licensing throughout the nation and ultimately would build rely on new discoveries. On the manufacturing side, requirements for how organizations label the different functions of an object (such as the shapes and size of a part or completion product) on the production line can make it easier for companies to utilize algorithms from one factory to another, without having to go through expensive retraining efforts.

Patent protections. Traditionally, in China, new innovations are quickly folded into the general public domain, making it hard for enterprise-software and AI players to realize a return on their large financial investment. In our experience, patent laws that safeguard intellectual property can increase financiers' confidence and bring in more financial investment in this area.

AI has the potential to improve crucial sectors in China. However, among company domains in these sectors with the most valuable use cases, there is no low-hanging fruit where AI can be executed with little extra financial investment. Rather, our research finds that unlocking maximum potential of this chance will be possible only with strategic investments and developments across a number of dimensions-with data, talent, innovation, and market partnership being primary. Working together, business, AI players, and government can attend to these conditions and make it possible for China to capture the amount at stake.